Polymorphisms in the p53 pathway

E C Pietsch1, O Humbey, M E Murphy

  • 1Division of Medical Sciences, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Oncogene
|March 22, 2006
PubMed

Insights

Polymorphisms in the p53 tumor suppressor gene and its target genes can impair function, influencing cancer risk and therapy efficacy. Understanding these genetic variations is crucial for personalized cancer treatment strategies.

Area of Science:

  • Oncology
  • Cancer Genetics
  • Molecular Biology

Background:

  • The p53 tumor suppressor gene is the most frequently mutated gene in human cancer, occurring in up to 50% of tumors.
  • p53's role in inducing growth arrest or apoptosis is critical for preventing cancer development.
  • Polymorphisms in p53 and its target genes that impair function are surprisingly common.

Purpose of the Study:

  • To review the nature of polymorphic variants in the p53 pathway.
  • To elucidate the mechanisms by which these polymorphisms impair p53 pathway function.
  • To discuss the impact of these polymorphisms on cancer risk and therapeutic outcomes.

Main Methods:

  • Review of existing literature on p53 gene and pathway polymorphisms.
  • Analysis of mechanisms by which polymorphisms affect protein function.
  • Discussion of implications for cancer risk and therapy.

Main Results:

  • Identified polymorphic variants in p53 and its target genes that compromise their tumor-suppressive functions.
  • Elucidated mechanisms of functional impairment by these polymorphisms.
  • Highlighted the emerging understanding of how these variations impact cancer risk and treatment.

Conclusions:

  • Polymorphisms in the p53 pathway represent a significant factor in cancer development and progression.
  • Future research should focus on mouse models and haplotype analyses of p53 variants for better insights.
  • Understanding inter-individual genotypic differences is key to advancing personalized cancer therapy and prognosis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...